Prospera Financial Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

Prospera Financial Services’s Portfolio BMRN Stock Details BMRN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$202K	Buy
2024 Q1	–	Sell
2023 Q4	$231K	Buy
2022 Q3	–	Sell
2022 Q2	$121K	Sell
2022 Q1	$130K	Buy
2020 Q4	–	Sell
2020 Q3	$29K	Buy